<DOC>
	<DOC>NCT01127529</DOC>
	<brief_summary>The overall objective is to collect and assess data on the treatment, safety, and treatment outcomes of subjects prescribed, receiving and participating in the Ceprotin treatment registry.</brief_summary>
	<brief_title>Ceprotin Treatment Registry</brief_title>
	<detailed_description />
	<mesh_term>Protein C Deficiency</mesh_term>
	<mesh_term>Protein C</mesh_term>
	<criteria>Participants for whom CEPROTIN therapy has been indicated and meeting the following criteria may be enrolled in this study: Signed and dated informed consent from either the participant or the participant's legally authorized representative prior to enrollment, as applicable Males and females of any age, including neonates, children, adolescents and adults Participant who received CEPROTIN or is initiating/receiving CEPROTIN treatment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>